Phillip Andrew Dennis - Chief Medical Officer at NovaBridge Biosciences

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
NBP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Phillip Andrew Dennis in NovaBridge Biosciences

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-16,703
Avg price
$0.6846
Total value
-$11,434

Net

Past year
Shares
-16,703
Share %
-100%
Total value
-$11,434

Reported holdings for Phillip Andrew Dennis in NovaBridge Biosciences

Form 4 holding Chief Medical Officer

NovaBridge Biosciences

Security class
Ordinary Shares
Shares / value
173,427
Estimated value
$123,133
Report date
18 Sep 2026
Price
$0.7100
Ownership
Direct
Form 4 holding Chief Medical Officer

NovaBridge Biosciences

Security class
Restricted Share Units
Shares / value
72,120
Estimated value
Report date
17 Sep 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Phillip Andrew Dennis in NovaBridge Biosciences

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .